about
Niacin, an old drug with a new twistNeurofurans, novel indices of oxidant stress derived from docosahexaenoic acidCyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation.Niacin and biosynthesis of PGD₂by platelet COX-1 in mice and humans.Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodellingTiming of expression of the core clock gene Bmal1 influences its effects on aging and survival.Eicosapentaenoic-acid-derived isoprostanes: synthesis and discovery of two major isoprostanesObesity in mice with adipocyte-specific deletion of clock component Arntl.Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VI.Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics.COX-2-derived prostacyclin modulates vascular remodeling.Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.L-Pgds but not H-Pgds deletion causes hypertension and accelerates thrombogenesis in miceNoninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS methodPCSK9 Inhibitor Use in the Real World: Data From the National Patient-Centered Research NetworkEffects of celecoxib on major prostaglandins in asthmaEgg yolk, source of bad cholesterol and good lipids?
P50
Q27002774-BE8F0589-3139-4AC6-903B-B5EE64C89B77Q28252451-92BD4D5B-CD5A-4F5E-904C-19C022D382E5Q33639514-957372DC-5742-45A3-BCC9-7F045E679230Q35367168-4B950CE0-022C-4329-BE9E-176E67169874Q35858061-CBE822CC-679D-4BB3-960B-6BF8DBD12EC1Q36342136-335F2813-AAE3-401C-8C02-6191FDF73DCEQ36909030-8D77C163-9BF2-4112-B086-37C6AAD8BC98Q36968492-0023E8AC-8B2A-4380-B351-BD1CB9A7E9BFQ37195570-03DA3258-77FF-4068-82AC-3FBCA6F719E5Q37358170-98727888-D723-4777-8308-7F3F046060E7Q37440033-CA4E0EA6-F84A-4634-B581-84AA668F2C8DQ40365888-37FD7BE4-8AFD-4AF3-A8E1-A5A36825EEADQ46499852-BD337D25-591D-497F-B5EC-7CEC60FF414DQ46745011-487896A1-31C1-49C8-93BA-474F9E3FB687Q46907241-FC0418E3-B1ED-4C9D-A4E4-39D66F326068Q57284969-52FD00D2-58E5-4DFD-B18B-50AE338042B9Q59124594-BE96189D-2CB5-4A05-9115-47C554B1F445Q64089041-6F71A4E1-E82A-411C-B2CC-241909BF910CQ85109700-C77FFA77-E375-4975-9E69-140FCF5F0A7AQ92574762-3E9FB884-5CCF-4110-92A1-1AA137EEE39C
P50
description
physician
@en
wetenschapper
@nl
name
Wenliang Song
@en
Wenliang Song
@nl
type
label
Wenliang Song
@en
Wenliang Song
@nl
prefLabel
Wenliang Song
@en
Wenliang Song
@nl
P21
P31
P496
0000-0002-1866-0635